ITeos Therapeutics Inc Ordinary Shares (NASDAQ:ITOS)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ITOS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ITOS

  • Market Cap$785.700m
  • SymbolNASDAQ:ITOS
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS46565G1040

Company Profile

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.

Latest ITOS news

Currently there for this company. Visit our news hub for other news .